Brief: HKEX Says Blackrock's Long Position In Wuxi Biologics Decreases To 4.64%
March 28 (Reuters) - HKEX:
* BLACKROCK'S LONG POSITION IN WUXI BIOLOGICS 2269.HK
DECREASES TO
4.64% ON MARCH 25 FROM 5.14%
Further company coverage: 2269.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln